Clinical Trial Update: A Phase 2 Dose-finding Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis [Phase 2]

View source ↗

Summary

Phase 2 dose-finding study of TS-172 in hyperphosphatemia patients on hemodialysis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperphosphatemia

Drugs mentioned

• TS-172

Snippet

Sponsor: Taisho Pharmaceutical Co., Ltd. | Conditions: Hyperphosphatemia Patients on Hemodialysis | Phase 2 | Status: COMPLETED